Scope
Reference
C382504
Description
Project title: NHS National Framework for Omalizumab commencing 1st February 2026
Offer reference number: CM/TNS/25/5734
Period of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Commercial tool
Establishes a framework
Framework
Maximum percentage fee charged to suppliers
0%
Framework operation description
Please refer to the ITO Documents for the Operation Description
Award method when using the framework
With competition
Contracting authorities that may use the framework
Establishing party only
Contract 2. Lot 1 - CM/TNS/25/5734
Suppliers (3)
- Celltrion Healthcare United Kingdom Limited
- MERCURY PHARMACEUTICALS LIMITED
- NOVARTIS PHARMACEUTICALS UK LIMITED
Contract value
- £87,433,000 excluding VAT
- £104,919,600 including VAT
Above the relevant threshold
Date signed
12 December 2025
Contract dates
- 1 February 2026 to 31 August 2027
- Possible extension to 31 August 2029
- 3 years, 7 months
Description of possible extension:
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKC - North East (England)
- UKD - North West (England)
- UKF - East Midlands (England)
- UKG - West Midlands (England)
- UKH - East of England
- UKJ - South East (England)
- UKK - South West (England)
Signed contract documents
CONTRACT COPY Documents UK7 Contract Details Notice - CM-TNS-25-5734 Omalizumab.pdf
CONTRACT COPY Documents UK7 Contract Details Notice - CM-TNS-25-5734 Omalizumab
Other information
Applicable trade agreements
- Government Procurement Agreement (GPA)
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Open procedure
Suppliers
Celltrion Healthcare United Kingdom Limited
- Companies House: 11685363
The Charter Building
Uxbridge
UB8 1JG
United Kingdom
Email: info@celltrionhc.com
Region: UKI74 - Harrow and Hillingdon
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 2. Lot 1 - CM/TNS/25/5734
MERCURY PHARMACEUTICALS LIMITED
- Companies House: 02619880
Dashwood House
London
EC2M 1QS
United Kingdom
Region: UKI31 - Camden and City of London
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 2. Lot 1 - CM/TNS/25/5734
NOVARTIS PHARMACEUTICALS UK LIMITED
- Companies House: 00119006
2nd Floor, The Westworks Building White City Place
London
W12 7FQ
United Kingdom
Region: UKI33 - Kensington & Chelsea and Hammersmith & Fulham
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 2. Lot 1 - CM/TNS/25/5734
Contracting authority
NHS England
- Public Procurement Organisation Number: PDPT-3135-BWWY
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
United Kingdom
Email: katie.noonan@nhs.net
Website: https://www.england.nhs.uk/
Region: UKI45 - Lambeth
Organisation type: Public authority - central government